Monogenic determinants of familial Alzheimer's disease: presenilin-2 mutations

被引:17
作者
Renbaum, P [1 ]
Levy-Lahad, E [1 ]
机构
[1] Shaare Zedek Med Ctr, Dept Internal Med, IL-91031 Jerusalem, Israel
关键词
Alzheimer's disease; presenilin-2; presenilin-1; APP; A beta; sel-12; apoptosis;
D O I
10.1007/s000180050220
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Presenilin-2 (PSZ) is one of three genes [amyloid precursor protein (APP), presenilin-1 (PSI) and PS2] shown to cause familial Alzheimer's disease (FAD), and is highly homologous to PS1. Currently demonstrated functions of PS2 include interactions with APP and AP, and participation in apoptotic pathways. PS2 FAD mutations influence APP processing in a manner predicted to promote amyloid formation and also enhance the proapoptotic effect of wild-type PS2. Other possible functions of PS2 are related to its homology to Notch pathway genes in Caenorhabditis elegans, suggesting it may have a developmental role. PS2-associated AD is the most reminiscent of the sporadic form of the disease in terms of older age of onset and longer disease duration. Since PS2 mutations are incompletely penetrant and age of onset in carriers is highly variable (40-88 years), elucidation of PS2 mechanisms may reveal factors which modify AD and are therapeutically relevant to sporadic AD.
引用
收藏
页码:910 / 919
页数:10
相关论文
共 74 条
[1]   DNA damage and apoptosis in Alzheimer's disease: Colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay [J].
Anderson, AJ ;
Su, JH ;
Cotman, CW .
JOURNAL OF NEUROSCIENCE, 1996, 16 (05) :1710-1719
[2]   PHENOTYPIC HETEROGENEITY IN FAMILIAL ALZHEIMERS-DISEASE - A STUDY OF 24 KINDREDS [J].
BIRD, TD ;
SUMI, SM ;
NEMENS, EJ ;
NOCHLIN, D ;
SCHELLENBERG, G ;
LAMPE, TH ;
SADOVNICK, A ;
CHUI, H ;
MINER, GW ;
TINKLENBERG, J .
ANNALS OF NEUROLOGY, 1989, 25 (01) :12-25
[3]   Wide range in age of onset for chromosome 1-related familial Alzheimer's disease [J].
Bird, TD ;
LevyLahad, E ;
Poorkaj, P ;
Sharma, V ;
Nemens, E ;
Lahad, A ;
Lampe, TH ;
Schellenberg, GD .
ANNALS OF NEUROLOGY, 1996, 40 (06) :932-936
[4]   FAMILIAL ALZHEIMERS-DISEASE IN AMERICAN DESCENDANTS OF THE VOLGA GERMANS - PROBABLE GENETIC FOUNDER EFFECT [J].
BIRD, TD ;
LAMPE, TH ;
NEMENS, EJ ;
MINER, GW ;
SUMI, SM ;
SCHELLENBERG, GD .
ANNALS OF NEUROLOGY, 1988, 23 (01) :25-31
[5]   Regional and cellular presenilin 2 (STM2) gene expression in the human brain [J].
Boissiere, F ;
Pradier, L ;
Delaere, P ;
Faucheux, B ;
Revah, F ;
Brice, A ;
Agid, Y ;
Hirsch, EC .
NEUROREPORT, 1996, 7 (12) :2021-2025
[6]   Cloning and characterization of the Drosophila presenilin homologue [J].
Boulianne, GL ;
LivneBar, I ;
Humphreys, JM ;
Liang, Y ;
Lin, C ;
Rogaev, E ;
StGeorgeHyslop, P .
NEUROREPORT, 1997, 8 (04) :1025-1029
[7]   Presenilin-I, presenilin-II, and VLDL-R associations in early onset Alzheimer's disease [J].
Brookes, AJ ;
Howell, WM ;
Woodburn, K ;
Johnstone, EC ;
Carothers, A .
LANCET, 1997, 350 (9074) :336-337
[8]   RELEASE OF EXCESS AMYLOID BETA-PROTEIN FROM A MUTANT AMYLOID BETA-PROTEIN PRECURSOR [J].
CAI, XD ;
GOLDE, TE ;
YOUNKIN, SG .
SCIENCE, 1993, 259 (5094) :514-516
[9]  
Capell A, 1997, J NEUROCHEM, V69, P2432
[10]   Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice [J].
Citron, M ;
Westaway, D ;
Xia, WM ;
Carlson, G ;
Diehl, T ;
Levesque, G ;
JohnsonWood, K ;
Lee, M ;
Seubert, P ;
Davis, A ;
Kholodenko, D ;
Motter, R ;
Sherrington, R ;
Perry, B ;
Yao, H ;
Strome, R ;
Lieberburg, I ;
Rommens, J ;
Kim, S ;
Schenk, D ;
Fraser, P ;
Hyslop, PS ;
Selkoe, DJ .
NATURE MEDICINE, 1997, 3 (01) :67-72